

Cleerly, a creator of a new standard of care for heart disease, has raised $43 million in Series B funding. Vensana Capital led the round with participation from other investors that included LRVHealth, New Leaf Venture Partners, DigiTx Partners, the American College of Cardiology and Cigna Ventures.
Source: Press Release